None listed
Conditions
Interventions
Trade Name: Esmeron
Product Name: rocuronium bromide
Product Code: Esmeron
Pharmaceutical Form: Injection*
Pharmaceutical form of the placebo: Injection*
Route of administration of the placebo: Intrav
Sponsors
Region Skåne
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Children, 1 month to 12 years, admitted for surgery at our hospital. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Suspected difficult intubation. Increased risk of regurtation and aspiration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Intravenous induction of an anaesthesia to a child is an established method in our department. Certain procedures requires tracheal intubation after administration of a muscle relaxant. If you want to avoid succinylcholine with its potential side effects you have non depolarizing blocking agents with a duration of action that may be too long in relation to the length of the procedure. The main objective of this study is to see whether adding a low dose muscle relaxant (rocuronium) to propofol and remifentanil would improve the intubating condition in children.;Secondary Objective: ;Primary end point(s): Will adding a low dose of rocuronium improve intubating conditions after induction with propofol and remifentanil. | — |
Countries
Sweden
Outcome results
None listed